{"id":35712,"date":"2025-07-16T02:25:03","date_gmt":"2025-07-16T06:25:03","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=35712"},"modified":"2025-07-16T02:25:05","modified_gmt":"2025-07-16T06:25:05","slug":"roberta-zappasodi-phd","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/roberta-zappasodi-phd","title":{"rendered":"Roberta Zappasodi, PhD"},"content":{"rendered":"\n<p>A common feature of tumors that respond to immunotherapy is the presence of effector T cells (Teff), which help attack cancer. However, Teff often struggle to function in tumors because cancer cells consume key nutrients like glucose that Teff need to function.<br><br>Dr. Roberta Zappasodi\u2019s previous research revealed that tumor cells not only deplete glucose rapidly but also disrupt nearby blood vessels, limiting access to oxygen and nutrients. This creates a hostile, nutrient-poor environment that weakens Teff responses. Surprisingly, regulatory T cells (Tregs), which suppress immune activity, thrive under these conditions and accumulate in tumors.<br><br>Dr. Zappasodi\u2019s preliminary data show that reducing the amount of glucose used by tumor cells improves immunotherapy responses by converting Tregs into Teff-like cells and restoring functional blood vessels. She will now investigate how this metabolic reprogramming occurs and how the converted Tregs contribute to anti-tumor immunity. These findings could reveal new ways to reprogram suppressive immune cells into cancer-fighting allies, potentially enhancing the effectiveness of immunotherapy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Research Focus<\/h2>\n\n\n\n<p><strong>T cells, metabolism, anti-tumor immunity<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<p><strong>Mechanisms of \u201cfragile\u201d intratumoral regulatory T cells supporting anti-tumor immunity<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A common feature of tumors that respond to immunotherapy is the presence of effector T cells (Teff), which help attack cancer. However, Teff often struggle to function in tumors because cancer cells [&hellip;]<\/p>\n","protected":false},"featured_media":35663,"template":"","tax_cancer_type":[455],"tax_grant_type":[485],"tax_award_year":[742],"tax_institutions":[538],"tax_location_states":[494],"class_list":["post-35712","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CLIP Investigator","quote":"","scientist_last_name":"Zappasodi","show_on_landing":true,"scientist_publish_until":"20280715"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Roberta Zappasodi, PhD - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roberta Zappasodi, PhD - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"A common feature of tumors that respond to immunotherapy is the presence of effector T cells (Teff), which help attack cancer. However, Teff often struggle to function in tumors because cancer cells [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T06:25:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd\",\"name\":\"Roberta Zappasodi, PhD - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp\",\"datePublished\":\"2025-07-16T06:25:03+00:00\",\"dateModified\":\"2025-07-16T06:25:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp\",\"width\":800,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roberta Zappasodi, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Roberta Zappasodi, PhD - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd","og_locale":"es_ES","og_type":"article","og_title":"Roberta Zappasodi, PhD - Cancer Research Institute","og_description":"A common feature of tumors that respond to immunotherapy is the presence of effector T cells (Teff), which help attack cancer. However, Teff often struggle to function in tumors because cancer cells [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd","og_site_name":"Cancer Research Institute","article_modified_time":"2025-07-16T06:25:05+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd","name":"Roberta Zappasodi, PhD - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp","datePublished":"2025-07-16T06:25:03+00:00","dateModified":"2025-07-16T06:25:05+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp","width":800,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/roberta-zappasodi-phd#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Roberta Zappasodi, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/07\/roberta-zappasodi-800x800-1.webp","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/35712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/35663"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=35712"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=35712"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=35712"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=35712"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=35712"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=35712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}